These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12478000)

  • 21. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
    Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
    Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
    Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
    Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
    Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
    Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin's lymphomas: immunologic prognostic studies.
    Hadzi-Pecova L; Petrusevska G; Stojanovic A
    Prilozi; 2007 Jul; 28(1):39-55. PubMed ID: 17921917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validity of the International Prognostic Index in non-Hodgkin's lymphomas of varying grades of malignancy].
    Bettini R; Caronni F; Maino C; Marzetta K; Sala D; Saccà V; Gorini M
    Recenti Prog Med; 2003 Nov; 94(11):494-500. PubMed ID: 14679917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 in non-Hodgkin's lymphoma.
    Cortes J; Kurzrock R
    Leuk Lymphoma; 1997 Jul; 26(3-4):251-9. PubMed ID: 9322887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.
    el-Din HM; Attia MA; Hamza MR; Khaled HM; Thoraya MA; Eisa SA
    Egypt J Immunol; 2004; 11(1):55-64. PubMed ID: 15724387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.
    Mok TS; Steinberg J; Chan AT; Yeo WM; Hui P; Leung TW; Johnson P
    Cancer; 1998 Jun; 82(12):2439-48. PubMed ID: 9635538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma.
    Legouffe E; Rodriguez C; Picot MC; Richard B; Klein B; Rossi JF; Commes T
    Leuk Lymphoma; 1998 Oct; 31(3-4):351-7. PubMed ID: 9869199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost determinants in aggressive non-Hodgkin's lymphoma.
    van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
    Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Iijima K
    Leuk Res; 2002 Mar; 26(3):241-8. PubMed ID: 11792412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor.
    Blay JY; Burdin N; Rousset F; Lenoir G; Biron P; Philip T; Banchereau J; Favrot MC
    Blood; 1993 Oct; 82(7):2169-74. PubMed ID: 8400266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A predictive model for aggressive non-Hodgkin's lymphoma.
    International Non-Hodgkin's Lymphoma Prognostic Factors Project
    N Engl J Med; 1993 Sep; 329(14):987-94. PubMed ID: 8141877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma.
    Lee HL; Eom HS; Yun T; Kim HJ; Park WS; Nam BH; Moon-Woo S; Lee DH; Kong SY
    Cytokine; 2008 Jul; 43(1):71-5. PubMed ID: 18502145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma.
    Ristamäki R; Joensuu H; Lappalainen K; Teerenhovi L; Jalkanen S
    Blood; 1997 Nov; 90(10):4039-45. PubMed ID: 9354673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
    Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R
    Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients.
    Warzocha K; Salles G; Bienvenu J; Bastion Y; Dumontet C; Renard N; Neidhardt-Berard EM; Coiffier B
    J Clin Oncol; 1997 Feb; 15(2):499-508. PubMed ID: 9053471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
    Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
    Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease.
    Bohlen H; Kessler M; Sextro M; Diehl V; Tesch H
    Ann Hematol; 2000 Mar; 79(3):110-3. PubMed ID: 10803931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.